Abstract
Much recent attention has been directed to the problem of bioavailability. While oral digitoxin appears to be essentially completely absorbed [28], the bioavailability of oral digoxin appears to be somewhere between 85% [3–5] and 50% [7]. Other digoxin preparations may be even less well absorbed. Because of this, parenteral doses of digoxin probably should be reduced to 50–85% of the corresponding oral dose when using oral digoxin of good bioavailability, while little or no such reduction appears necessary for digitoxin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Augsberger, A. (1954). Quantitatives zur therapie mit herzglycosiden. Klin. Wschr., 32:945.
Beller, G. A., Smith, T. W., and Abelmann, W. H. (1971). Digitalis intoxication. A prospective clinical study with serum level correlations. New Engl. J. Med. 284:989–991.
Doherty, J. E., Flanigan, W. J., and Murphy, M. L. (1970). Tritiated digoxin. XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers. Circulation 42:861–814.
Doherty, J. E., and Perkins, W. H. (1962). Studies with tritiated digoxin in human subjects after intravenous administration. Am. Heart J. 63:528–536.
Doherty, J. E., Perkins, W. H., and Mitchell, G. K. (1961). Tritiated digoxin studies in human subjects. Arch. Int. Med. 108:531–539.
Goicoechea, F. J., Haywood, J., deGuzman, M., Jelliffe, R. W., Gallardo, C., and Rodman, J. (1974). Kinetics of procainamide after single and multiple oral doses. Circulation 49/50:Suppl.: III–228.
Greenblatt, D. J., Duhme, D. W., Koch-Weser, J., and Smith, T. W. (1973). Evaluation of digoxin bioavailability in single-dose studies. New Engl. J. Med 289:651–654.
Harter, J. G., Shelly, J. P., and Steers, A. W. (1974). Digoxin—The regulatory viewpoint. Circulation 49:395–398.
Jelliffe, R. W. (1967). A mathematical analysis of digitalis kinetics in patients with normal and reduced renal function. Math Biosci. 7:305–325.
Jelliffe, R. W. (1969). Therapeutic guidelines. Administration of digoxin. Dis. Chest 56:56–60.
Jelliffe, R. W. (1971). Factors to consider in planning digoxin therapy J. Chron. Dis. 24:401–416.
Jelliffe, R. W., Buell, J., and Kalaba, R. (1972). Reduction of digitalis toxicity by computer-assisted glycoside dosage regimens. Ann. Int. Med. 77:291–906.
Jelliffe, R. W., Buell, J., Kalaba, R., and Ivler, D. (1972). A computer program for streptomycin dosage. Fed. Proc. 37:576.
Jelliffe, R. W., Buell, J., Kalaba, R., Sridhar, R., and Rockwell, R. (1970). A mathematical study of the metabolic conversion of digitoxin to digoxin in man. Math. Biosci. 6:387–403.
Jelliffe, R. W., Buell, J., Kalaba, R. Sridhar, R., and Rockwell, R. (1970). A computer program for digitalis dosage regimens. Math. Biosci. 9:179–193.
Jelliffe, R. W., Buell, J., Kalaba, R., Sridhar, R., Rockell, R. W., and Wagner, J. G. (]970). An improved method of digitoxin therapy. Ann. Int. Med. 72:453–464.
Jelliffe, R. W., Goicoechea, F. J., Tuey, D., Wyman, M. G., Rodman, J., and Goldreyer, B. (1975). An improved computer program for lidocaine infusion regimens. Paper presented at the Western Society for Clinical Research, February 7, Carmel, California.
Jelliffe, R. W., and Jelliffe, S. M. (1972). A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex, and weight. Math Biosci. 74:17–24.
Jelliffe, R. W., Knight, R., Buell, J., Kalaba, R., and Rockwell, R. (1970). Computer assistance for gentamicin therapy. Clin. Res. 75:441.
Jelliffe, R. W., and Stephenson, R. G. (1969). A fluorometric determination of myocardial digoxin at autopsy. Am. J. Clin. Path. 57:347–357.
Knight, R., Buell, J., Kalaba, R., Rockwell, R., and Jelliffe, R. W. (1970). Computer-assisted kanamycin dose programs. Clin. Res. 18:131.
Kolendorf, K., Christiansen, N. J. B., Siersbaek-Nielsen, K., and Moholm Hansen, J. (1972). Serum digoxin after dosage regimen based on body weight and renal function. Lancet 2:326.
Levy, G., and Gibaldi, M. (1974). Bioavailability of drugs. Circulation 49:391–394.
Ogilvie, R. L., and Ruedy, J. (1972). An educational program in digitalis therapy. J. Am. Med. Assoc. 222:30–55.
Rodensky, P. L., and Wasserman, F. (1961). Observations on digitalis intoxication. Arch. Int. Med. 705:61–78.
von Capeller, D., Copeland, G. D., and Stern, T. N. (1959). Digitalis intoxication: A clinical report of 148 cases. Ann. Int. Med. 50:869–878.
Wang, S. P., and Chiang, B. N. (1973). An appraisal of Jelliffe’s method, in digoxin therapy. Symposium, Republic of China Society of Cardiology, September 30.
Weissler, A. M., Snyder, J. R., Schoenfeld, C. D., and Cohen, S. (1966). Assay of digitalis glycosides in man. Am. J. Cardiol. 77:768–780.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Jelliffe, R.W. (1978). Techniques for Establishing Appropriate Dose Regimens of Digitalis. In: Critical Care Medicine Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-9932-5_25
Download citation
DOI: https://doi.org/10.1007/978-1-4612-9932-5_25
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9934-9
Online ISBN: 978-1-4612-9932-5
eBook Packages: Springer Book Archive